Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ERK1/2 inhibitor 2 (ASTX029) is a selective and orally bioavailable extracellular signal-regulated kinases 1 and 2 (ERK 1/2) inhibitor, with potential antineoplastic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 155.00 | |
25 mg | In stock | $ 247.00 | |
50 mg | In stock | $ 447.00 | |
100 mg | In stock | $ 659.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 125.00 |
Description | ERK1/2 inhibitor 2 (ASTX029) is a selective and orally bioavailable extracellular signal-regulated kinases 1 and 2 (ERK 1/2) inhibitor, with potential antineoplastic activity. |
Synonyms | ASTX-029, ASTX029 |
Molecular Weight | 584.04 |
Formula | C29H31ClFN5O5 |
CAS No. | 2095719-92-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (94.17 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ERK1/2 inhibitor 2 2095719-92-7 MAPK ERK ERK-1/2 inhibitor 2 Extracellular signal regulated kinases Inhibitor ASTX-029 ASTX029 inhibit ASTX 029 inhibitor